Quad-Cities Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Buy
413
+11
+3% +$11.2K 0.18% 124
2026
Q1
$370K Hold
402
0.15% 140
2025
Q4
$432K Buy
402
+1
+0.2% +$956 0.18% 118
2025
Q3
$306K Buy
401
+1
+0.3% +$744 0.13% 146
2025
Q2
$312K Hold
400
0.14% 138
2025
Q1
$330K Buy
400
+1
+0.3% +$832 0.16% 123
2024
Q4
$308K Buy
399
+21
+6% +$17.4K 0.15% 131
2024
Q3
$335K Hold
378
0.17% 125
2024
Q2
$342K Buy
378
+1
+0.3% +$800 0.19% 112
2024
Q1
$294K Sell
377
-22
-6% -$15.7K 0.17% 126
2023
Q4
$250K Buy
+399
New +$233K 0.15% 144
2019
Q4
Sell
-145
Closed -$16K 464
2019
Q3
$16K Hold
145
0.01% 526
2019
Q2
$16K Buy
145
+1
+0.7% +$118 0.01% 535
2019
Q1
$19K Sell
144
-199
-58% -$24.2K 0.02% 499
2018
Q4
$40K Buy
343
+1
+0.3% +$112 0.04% 361
2018
Q3
$36K Hold
342
0.03% 409
2018
Q2
$29K Buy
+342
New +$28.1K 0.03% 451

Other funds holding LLY

Quad-Cities Investment Group's LLY Position: Q2 2026 in Review

Quad-Cities Investment Group increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $11.2K and bringing the position to 413 shares worth $495K. The position accounts for 0.18% of the portfolio, ranked #124.

Quad-Cities Investment Group first reported a position in LLY in Q2 2018 and has held it in 17 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Quad-Cities Investment Group held 413 shares of Eli Lilly worth $495K as of Q2 2026.
  • Quad-Cities Investment Group bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.18% of Quad-Cities Investment Group's portfolio in Q2 2026, its #124 holding.
  • Quad-Cities Investment Group first reported a position in Eli Lilly in Q2 2018 and has held it in 17 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Quad-Cities Investment Group's 13F filing for Q2 2026, filed 7 Jul 2026.